CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-14 | Lebwohl David EVP, Chief Medical Officer | Option exercise · Stock Option (right to buy) | −2,400 | 182,477 | ||
| 2021-10-11 | Crowley John F Director | Option exercise | +2,500 | $18.83 | $47K | 4,594 |
| 2021-10-11 | Crowley John F Director | Sale | −2,500 | $119.55 | $299K | 2,094 |
| 2021-10-11 | Crowley John F Director | Option exercise · Stock Option (right to buy) | −2,500 | 25,500 | ||
| 2021-10-05 | Crowley John F Director | Option exercise | +10,000 | $18.83 | $188K | 12,094 |
| 2021-10-05 | Crowley John F Director | Sale | −1,280 | $128.83 | $165K | 10,814 |
| 2021-10-05 | Crowley John F Director | Sale | −2,915 | $129.88 | $379K | 7,899 |
| 2021-10-05 | Crowley John F Director | Sale | −3,759 | $130.92 | $492K | 4,140 |
| 2021-10-05 | Crowley John F Director | Sale | −1,846 | $131.74 | $243K | 2,294 |
| 2021-10-05 | Crowley John F Director | Sale | −200 | $132.84 | $27K | 2,094 |
| 2021-10-05 | Crowley John F Director | Option exercise · Stock Option (right to buy) | −10,000 | 28,000 | ||
| 2021-09-24 | Lebwohl David EVP, Chief Medical Officer | Option exercise | +7,923 | $12.62 | $100K | 8,714 |
| 2021-09-24 | Lebwohl David EVP, Chief Medical Officer | Option exercise · Stock Option (right to buy) | −7,923 | 184,877 | ||
| 2021-09-21 | Lebwohl David EVP, Chief Medical Officer | Option exercise | +2,400 | $12.62 | $30K | 3,191 |
| 2021-09-21 | Lebwohl David EVP, Chief Medical Officer | Sale | −2,400 | $149.81 | $360K | 791 |
| 2021-09-21 | Lebwohl David EVP, Chief Medical Officer | Option exercise · Stock Option (right to buy) | −2,400 | 192,800 | ||
| 2021-09-07 | Goddard Glenn EVP, Chief Financial Officer | Option exercise | +3,482 | $14.58 | $51K | 3,482 |
| 2021-09-07 | Goddard Glenn EVP, Chief Financial Officer | Sale | −3,482 | $180.12 | $627K | 0 |
| 2021-09-07 | Goddard Glenn EVP, Chief Financial Officer | Option exercise · Stock Option (right to buy) | −3,482 | 12,451 | ||
| 2021-09-01 | LEONARD JOHN M President and CEO | Option exercise | +28,750 | $23.46 | $674K | 748,055 |
Page 15 of 40 · 783 trades